Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer.

Ory WieselOran ZlotnikSarah MorgensternMaya TsurNikolai MenasherovYael FefermanIrit Ben-AharonHanoch Kashtan

Published in: American journal of clinical oncology (2022)

FPR is a predictor of improved OS. SCC and radiation therapy-based protocol were identified as major prediction factors of FPR in patients with esophageal and GEJ cancers.

Keyphrases

radiation therapy
locally advanced
rectal cancer
neoadjuvant chemotherapy
randomized controlled trial
lymph node
squamous cell carcinoma
mesenchymal stem cells
bone marrow